Efficacy News and Research

RSS
rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

MHRA approves new formulation of Pfizer BioNTech COVID-19 vaccine for 5-11 year olds

MHRA approves new formulation of Pfizer BioNTech COVID-19 vaccine for 5-11 year olds

Study suggests nitazoxanide fails to reduce the severity of SARS-CoV-2

Study suggests nitazoxanide fails to reduce the severity of SARS-CoV-2

Scientists identify a panel of nanobodies with good neutralizing efficacy against SARS-CoV-2 variants of concern

Scientists identify a panel of nanobodies with good neutralizing efficacy against SARS-CoV-2 variants of concern

How can we increase confidence in the COVID-19 vaccine?

How can we increase confidence in the COVID-19 vaccine?

Researchers identify new mechanism that impairs cancer cell proliferation and induces death

Researchers identify new mechanism that impairs cancer cell proliferation and induces death

National U.S trial confirms effectiveness of mRNA COVID-19 vaccines

National U.S trial confirms effectiveness of mRNA COVID-19 vaccines

Diagnostic assays that use the 2019-nCoV-N1 primer-probe are unlikely to be impacted by Omicron variant

Diagnostic assays that use the 2019-nCoV-N1 primer-probe are unlikely to be impacted by Omicron variant

Stabilizing the long-term endemic behavior of COVID-19

Stabilizing the long-term endemic behavior of COVID-19

Efficacy of the mRNA-1273 vaccine against emerging COVID-19 variants

Efficacy of the mRNA-1273 vaccine against emerging COVID-19 variants

Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants

Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants

Clinical trial shows preliminary efficacy of all-oral regimen for patients with lenalidomide-refractory multiple myeloma

Clinical trial shows preliminary efficacy of all-oral regimen for patients with lenalidomide-refractory multiple myeloma

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

An Omicron wave predicted for England from December 2021 to April 2022

An Omicron wave predicted for England from December 2021 to April 2022

New oral pill for COVID-19 home treatment

New oral pill for COVID-19 home treatment

New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant

New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant

Omicron variant of SARS-CoV-2 exhibits striking antibody evasion

Omicron variant of SARS-CoV-2 exhibits striking antibody evasion

Reduced antibody-mediated neutralization by the SARS-CoV-2 Omicron variant

Reduced antibody-mediated neutralization by the SARS-CoV-2 Omicron variant

Anti-SARS-CoV-2 antibody infusion shown to demonstrate robust immune response following COVID-19 vaccination

Anti-SARS-CoV-2 antibody infusion shown to demonstrate robust immune response following COVID-19 vaccination

Study offers an analysis of fungicide resistance and informs management strategies

Study offers an analysis of fungicide resistance and informs management strategies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.